Lack of barbering behavior in the phospholipase Cβ1 mutant mouse: A model animal for schizophrenia

Neurobiology of Grooming Behavior

Volumn , Issue , 2010, Pages 131-144

  Shin, Hee Sup ^a   Kim, Daesoo ^b   Koh, Hae Young ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885832385     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511676109.008     Document Type: Chapter

References (55)

1. Andreasen NC (1995): Symptoms, signs, and diagnosis of schizophrenia. Lancet 346:477-81.
2. Andrieux A, Salin PA, Vernet M et al. (2002): The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neurolepticsensitive behavioral disorders. Genes Dev 16:2350-64.
3. Arguello PA and Gogos JA (2006): Modeling madness in mice: one piece at a time. Neuron 52:179-96.
4. Arinami T, Ohtsuki T, Ishiguro H et al. (2005): Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet 77: 937-44.
5. Bourre JM, Dumont O, Piciotti M et al. (1991): Essentiality of omega 3 fatty acids for brain structure and function. World Rev Nutr Diet 66:103-17.
6. Braff DL and Freedman R (2002): Endophenotypes in Studies of the Genetics of Schizophrenia. Philadelphia: Lippincott Williams & Wilkins.
7. Brun P, Begou M, Andrieux A et al. (2005): Dopaminergic transmission in STOP null mice. J Neurochem 94:63-73.
8. Cheli V, Adrover M, Blanco C et al. (2006): Knocking-down the NMDAR1 subunit in a limited amount of neurons in the rat hippocampus impairs learning. J Neurochem 97 Suppl 1:68-73.
9. Chuang SC, Bianchi R, Kim D, Shin HS and Wong RK (2001): Group I metabotropic glutamate receptors elicit epileptiform discharges in the hippocampus through PLCbeta1 signaling. J Neurosci 21:6387-94.
10. Crawley JN (2004): Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disabil Res Rev 10:248-58.
11. Creese I and Iversen SD (1975): The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83:419-36.
12. Dias R and Aggleton JP (2000): Effects of selective excitotoxic prefrontal lesions on acquisition of nonmatching-and matching-to-place in the T-maze in the rat: differential involvement of the prelimbic-infralimbic and anterior cingulate cortices in providing behavioural flexibility. Eur J Neurosci 12:4457-66.
13. Drevets WC, Gautier C, Price JC et al. (2001): Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49: 81-96.
14. du Bois TM, Deng C and Huang XF (2005): Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29:878-88.
15. Elvevag B and Goldberg TE (2000): Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 14:1-21.
16. Fradley RL, O'Meara GF, Newman RJ et al. (2005): STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Res 163:257-64.
17. Gainetdinov RR, Wetsel WC, Jones SR et al. (1999): Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401.
18. Gainetdinov RR, Mohn AR and Caron MG (2001): Genetic animal models: focus on schizophrenia. Trends Neurosci 24:527-33.
19. Gerber DJ, Sotnikova TD, Gainetdinov RR et al. (2001): Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci USA 98:15312-17.
20. Geyer MA, Krebs-Thomson K, Braff DL and Swerdlow NR (2001): Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156:117-54.
21. Gogos JA and Gerber DJ (2006): Schizophrenia susceptibility genes: emergence of positional candidates and future directions. Trends Pharmacol Sci 27: 226-33.
22. Gould TD and Gottesman, II (2006): Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav 5:113-19.
23. Hanlon FM, Weisend MP, Hamilton DA et al. (2006): Impairment on the hippocampal-dependent virtual Morris water task in schizophrenia. Schizophr Res 87:67-80.
24. Hannan AJ, Blakemore C, Katsnelson A et al. (2001): PLC-beta1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex. Nat Neurosci 4:282-8.
25. Kellendonk C, Simpson EH, Polan HJ et al. (2006): Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49:603-15.
26. Kim D, Jun KS, Lee SB et al. (1997): Phospholipase C isozymes selectively couple to specific neurotransmitter receptors. Nature 389:290-3.
27. Koh HY, Kim D, Lee J, Lee S and Shin HS (2008): Deficits in social behavior and sensorimotor gating in mice lacking phospholipase C_1. Genes Brain Behav 7: 120-8.
28. Laruelle M, Abi-Dargham A, van Dyck CH et al. (1996): Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93:9235-40.
29. Laruelle M, Abi-Dargham A, Gil R, Kegeles L and Innis R (1999): Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46:56-72.
30. Lewis DA and Lieberman JA (2000): Catching up on schizophrenia: natural history and neurobiology. Neuron 28:325-34.
31. Lijam N, Paylor R, McDonald MP et al. (1997): Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell 90:895-905.
32. Lin XH, Kitamura N, Hashimoto T, Shirakawa O and Maeda K (1999): Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia. Biol Psychiatry 46:1665-71.
33. Long JM, LaPorte P, Paylor R and Wynshaw-Boris A (2004): Expanded characterization of the social interaction abnormalities in mice lacking Dvl1. Genes Brain Behav 3:51-62.
34. McOmish CE, Burrows EL, Howard M and Hannan AJ (2008a): PLC-beta1 knockout mice as a model of disrupted cortical development and plasticity: behavioral endophenotypes and dysregulation of RGS4 gene expression. Hippocampus 18:824-34.
35. McOmish CE, Burrows E, Howard M et al. (2008b): Phospholipase C-beta1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration. Mol Psychiatry 13:661-72.
36. Messeri P, Eleftheriou BE and Oliverio A (1975): Dominance behavior: a phylogenetic analysis in the mouse. Physiol Behav 14:53-8.
37. Miyakawa T, Leiter LM, Gerber DJ et al. (2003): Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci USA 100:8987-92.
38. Mohn AR, Gainetdinov RR, Caron MG and Koller BH (1999): Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-36.
39. Oude Weernink PA, Han L, Jakobs KH and Schmidt M (2006): Dynamic phospholipid signaling by G protein-coupled receptors. Biochim Biophys Acta 1768:888-900.
40. Peruzzi D, Aluigi M, Manzoli L et al. (2002): Molecular characterization of the human PLC beta1 gene. Biochim Biophys Acta 1584:46-54.
41. Powell CM and Miyakawa T (2006): Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? Biol Psychiatry 59:1198-207.
42. Rhee SG and Bae YS (1997): Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem272:15045-8.
43. Robertson GS, Hori SE and Powell KJ (2006): Schizophrenia: an integrative approach to modelling a complex disorder. J Psychiatry Neurosci 31:157-67.
44. Russig H, Spooren W, Durkin S, Feldon J and Yee BK (2004): Apomorphine-induced disruption of prepulse inhibition that can be normalised by systemic haloperidol is insensitive to clozapine pretreatment. Psychopharmacology (Berl) 175:143-7.
45. Schneider CW and Chenoweth MB (1970): Effects of hallucinogenic and other drugs on the nest-building behaviour of mice. Nature 225:1262-3.
46. Shin J, Kim D, Bianchi R, Wong RK and Shin HS (2005): Genetic dissection of theta rhythm heterogeneity in mice. Proc Natl Acad Sci USA 102:18165-70.
47. Shirakawa O, Kitamura N, Lin XH, Hashimoto T and Maeda K (2001): Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 25:867-77.
48. Spector AA and Yorek MA (1985): Membrane lipid composition and cellular function. J Lipid Res 26:1015-35.
49. Strozik E and Festing MF (1981): Whisker trimming in mice. Lab Anim 15:309-12.
50. Turetsky BI, Calkins ME, Light GA et al. (2007): Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull 33:69-94.
51. van den Buuse M, Garner B, Gogos A and Kusljic S (2005): Importance of animal models in schizophrenia research. Aust N Z J Psychiatry 39:550-7.
52. Watanabe M, Nakamura M, Sato K et al. (1998): Patterns of expression for the mRNA corresponding to the four isoforms of phospholipase C beta in mouse brain. Eur J Neurosci 10:2016-25.
53. Weike AI, Bauer U and Hamm AO (2000): Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry 47:61-70.
54. Yee BK, Keist R, von Boehmer L et al. (2005): A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. Proc Natl Acad Sci USA 102:17154-9.
55. Zeng H, Chattarji S, Barbarosie M et al. (2001): Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 107:617-29.